Advisory Board Members
Joseph Bertino, MD, Member of Advisory Board
Dr. Joseph Bertino currently serves as Director, Cancer Institute of New Jersey (elected February 1, 2007). He has served as Past President of the American Association of Cancer Research, an organization of over 20,000 researchers worldwide. Since 2002, Dr. Bertino has served as Associate Director of the Cancer Institute of New Jersey, and Professor of Medicine and Pharmacology at the University of Medicine and Dentistry at the Robert Wood Johnson Medical School in New Jersey. He was appointed Chief Scientific Officer of the Cancer Institute of New Jersey in 2004. Prior to joining the Cancer Institute of New Jersey and Robert Wood Johnson Medical School, Dr. Bertino served as Chairman of Molecular Pharmacology and Therapeutics Program, and Member and Co-head of the Program in Developmental Therapy and Clinical Investigation at Memorial Sloan-Kettering Institute for Cancer Research. From 1973 to 1986, Dr. Bertino was Director of the Yale Comprehensive Cancer Center, including Director of the Center and Associate Director of Clinical Research. Dr. Bertino has been internationally recognized for his role in finding curative treatments for leukemia and lymphoma.
Roy G. Smith, PhD, Member of the Advisory Board
Dr. Roy G. Smith is currently the Director of the Huffington Center on Aging, Professor in the Department of Molecular and Cellular Biology, and Professor in the Department of Medicine at Baylor College of Medicine. Prior to rejoining the faculty at Baylor, Dr. Smith was at Merck Research Laboratories for eleven (11) years where he served as Vice President of Basic Research. At Merck he was responsible for identifying new drug targets for metabolic diseases and drugs that would improve the quality of life in the elderly.
Pramod Srivastava, PhD, Member of the Advisory Board
Dr. Pramod Srivastava is the scientific founder of Antigenics, (a publicly traded company) and has served as chairman of the scientific advisory board since inception. Dr. Srivastava is a professor and Chairman of the Department of immunology at the University of Connecticut, where he holds an endowed chair in cancer immunology and is the director of the Center for Immunotherapy of Cancer and Infectious Diseases. Dr. Srivastava earned his Ph.D. in biochemistry from the Centre for Cellular and Molecular Biology, Hyderabad, India, and received his postdoctoral training at Yale University and the Sloan-Kettering Institute for Cancer Research. Dr. Srivastava serves on the scientific advisory council of the Cancer Research Institute, New York, and was a member of the Experimental Immunology Study Section of the National Institutes of Health of the United States government from 1994 until 1999. He has been inducted into the Roll of Honor of the International Union Against Cancer. He is among the founding members of the Academy of Cancer Immunology.